Diederich N, Goetz C G, Comella C L
Klinik für Neurochirurgie der Universität Köln.
Klin Wochenschr. 1990 Oct 3;68(19):935-41. doi: 10.1007/BF01646651.
At this point the treatment of dystonias remains highly empirical. Secondary dystonias, especially those related to specific drug treatment, have to be ruled out carefully. A few dystonic subgroups respond well to levodopa medication. In the other syndromes, anticholinergics are the usual first choice. In focal conditions botulinum toxin injections seem to be the most effective regimen, although there are only a few long-term studies. Surgical procedures are an ultimate option.
目前,肌张力障碍的治疗仍高度依赖经验。必须仔细排除继发性肌张力障碍,尤其是那些与特定药物治疗相关的肌张力障碍。少数肌张力障碍亚组对左旋多巴治疗反应良好。在其他综合征中,抗胆碱能药物通常是首选。在局限性疾病中,肉毒杆菌毒素注射似乎是最有效的治疗方案,尽管长期研究较少。手术治疗是最终选择。